| Product details | Supply Impact Dates | Further Details |
|---|---|---|
VORCON voriconazole 200 mgAUST R: 235933 Active Ingredients: voriconazole Dosage From: Injection, powder for |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |
VORICONAZOLE WOCKHARDT voriconazole 200 mgAUST R: 267013 Active Ingredients: voriconazole Dosage From: Injection, powder for |
From: 01 Apr 2023 To: 31 Dec 2026 |
Shortage Status: Current Availability: Unavailable Reason: Commercial Changes / Commercial viability |
VFEND voriconazole 200mgAUST R: 82503 Active Ingredients: voriconazole Dosage From: Injection, powder for |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |
VFEND voriconazole 50mgAUST R: 82507 Active Ingredients: voriconazole Dosage From: Tablet, film coated |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |
VORICONAZOLE SANDOZ voriconazole 50mgAUST R: 207786 Active Ingredients: voriconazole Dosage From: Tablet, film coated |
From: 18 Dec 2025 To: 23 Jul 2026 |
Shortage Status: Resolved Availability: Available Reason: Manufacturing |
VTTACK voriconazole 200mgAUST R: 206985 Active Ingredients: voriconazole Dosage From: Tablet, film coated |
From: 04 Sep 2026 To: 31 Mar 2027 |
Shortage Status: Current Availability: Limited Availability Reason: Manufacturing |
VTTACK voriconazole 50mgAUST R: 206983 Active Ingredients: voriconazole Dosage From: Tablet, film coated |
From: 23 Oct 2026 To: 31 Mar 2027 |
Shortage Status: Anticipated Availability: Available Reason: Manufacturing |
VFEND voriconazole 200mgAUST R: 82505 Active Ingredients: voriconazole Dosage From: Tablet, film coated |
From: To: |
Shortage Status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability |